C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells. Journal of Analytical Oncology, [S. l.], v. 2, n. 4, p. 195–208, 2013. DOI: 10.6000/1927-7229.2013.02.04.2. Disponível em: https://neoplasiaresearch.com/index.php/jao/article/view/87. Acesso em: 28 jun. 2026.